A Phase 3 Clinical Study Patients With Androgenetic Alopecia (AGA)
NCT05135468
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class
Conditions
AGA
Interventions
DRUG:
CU-40102 Spray
Sponsor
Cutia Therapeutics（Wuxi）Co.,Ltd